Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke
Table 4
Effect of resveratrol on the lipid profile.
Lipid profile
Resveratrol 100 mg group
Resveratrol 200 mg group
Control group
M ± SD
ES
M ± SD
ES
M ± SD
ES
Serum cholesterol (mg/dL)
Initial
257.56 ± 23.89
—
256.61 ± 22.23
—
255.14 ± 22.08
—
At 6 months
236.75 ± 22.82
0.87
236.16 ± 22.61
0.92
247.25 ± 21.67
0.36
At 12 months
221.52 ± 21.75
0.67
220.44 ± 21.56
0.70
231.41 ± 20.78
0.73
HDL cholesterol (mg/dL)
Initial
39.27 ± 5.27
—
39.36 ± 5.16
—
38.76 ± 5.29
—
At 6 months
43.78 ± 5.28
0.86
43.92 ± 5.18
0.88
40.17 ± 5.21
0.27
At 12 months
45.87 ± 5.31
0.40
46.12 ± 5.11
0.42
42.02 ± 5.14
0.36
LDL cholesterol (mg/dL)
Initial
143.34 ± 15.41
142.82 ± 15.26
143.48 ± 15.46
At 6 months
127.66 ± 13.88
1.02
125.01 ± 13.11
1.04
137.92 ± 13.83
0.36
At 12 months
124.21 ± 13.67
0.25
123.22 ± 13.13
0.29
135.21 ± 13.60
0.20
Triglycerides (mg/dL)
Initial
195.36 ± 20.16
—
195.69 ± 20.24
—
194.45 ± 20.24
—
At 6 months
172.73 ± 18.49
1.12
170.75 ± 18.23
1.23
177.54 ± 19.01
0.84
At 12 months
158.78 ± 16.85
0.75
156.28 ± 16.28
0.79
166.28 ± 17.77
0.59
Values are represented as mean ± SD ( patients in the resveratrol 100 mg group; patients in the resveratrol 200 mg group; and patients in the control group); versus initial value; <0.05 versus control group value; <0.05 versus resveratrol 200 mg group value.
